Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Relmada Therapeutics (RLMD) Return on Capital Employed (2016 - 2026)

Relmada Therapeutics has reported Return on Capital Employed over the past 2 years, most recently at 123.26% for Q1 2014.

  • Quarterly Return on Capital Employed changed N/A to 123.26% in Q1 2014 from the year-ago period, while the trailing twelve-month figure was 123.26% through Feb 2014, changed N/A year-over-year, with the annual reading at 310.78% for FY2013, N/A changed from the prior year.
  • Return on Capital Employed was 123.26% for Q1 2014 at Relmada Therapeutics, down from 157.2% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 222.38% in Q2 2013 and troughed at 123.26% in Q1 2014.